Asthma Clinical Trials in Houston, TX

17 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma	Phase 3	Teva Branded Pharmaceutical Products R&D LLC	<1 mi
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma	Phase 2	Sanofi	<1 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma	Phase 3	AstraZeneca	<1 mi
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)	Phase 3	Generate Biomedicines	<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma	Phase 3	AstraZeneca	<1 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)	—	Duke University	<1 mi
Individualizing Treatment for Asthma in Primary Care (Full Study)	Phase 4	DARTNet Institute	<1 mi
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice	—	Sanofi	<1 mi
Metformin IN Asthma for Overweight and Obese Individuals (MINA)	Phase 2	Johns Hopkins University	<1 mi
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)	Phase 3	Sanofi	<1 mi
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma	Phase 2	Pfizer	<1 mi
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment	Phase 3	AstraZeneca	<1 mi
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma	Phase 2	Incyte Corporation	15 mi
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)	Phase 3	Generate Biomedicines	19 mi
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids	Phase 2	AstraZeneca	19 mi
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)	Phase 2	Connect Biopharm LLC	24 mi
Viral Mucosal Reprogramming	Phase 2	The University of Texas Medical Branch, Galveston	47 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.